Atropine Sulfate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Accord Healthcare Inc. with status Current. The shortage was first posted on 01/01/2012. Reported reason: Requirements related to complying with good manufacturing practices
Shortage Details
- Status
- Current
- Company
- Accord Healthcare Inc.
- Package NDC
- 16729-512-43
- Dosage Form
- Injection
- Presentation
- Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43)
- Initial Posting
- 01/01/2012
- Revised Date
Reason
Requirements related to complying with good manufacturing practices